Market Research Trends

The global downstream processing market is predicted to reach $24.9 billion by the end of 2022, up from $22.0 billion in 2021. Additionally, as biopharmaceutical enterprises and contract research organisations increase their use, global demand for downstream processing items is predicted to grow at an 11.3% CAGR between 2022 and 2032, reaching a market worth of US$ 72.3 billion by 2032. The chromatography columns and resins category accounted for around 37.9% of the worldwide downstream processing market in 2021, and this dominance is likely to continue throughout the forecast period (2022 to 2032). Downstream processing is utilised to create antibiotics, antibodies, hormones, and vaccines, as well as industrial enzymes. Downstream processing involves the purification and recovery of biosynthetic products produced from natural sources such as animal and plant tissues. The downstream processing industry is driven by rising demand for biopharmaceuticals and rising R&D spending on th...

The global downstream processing market was valued at $22.0 billion in 2021 and is expected to reach $24.9 billion by the end of 2022. Furthermore, with increasing adoption among biopharmaceutical companies and contract research organisations, overall demand for downstream processing products is expected to grow at an 11.3% CAGR between 2022 and 2032, totalling a market valuation of US$ 72.3 Billion by 2032. Based on product, the chromatography columns and resins segment accounted for approximately 37.9% of the global downstream processing market in 2021, and it is expected to maintain its dominance throughout the forecast period (2022 to 2032). Downstream processing is used to manufacture antibiotics, antibodies, hormones, vaccines and also used for the production of industrial enzymes. In downstream processing, the purification and recovery of biosynthetic products is done that are derived from natural sources such as tissues of animals and plants. The downstream processin...